Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Placebo associated with improvement and side effects in treatment of BPH

April 16, 1997

GG-745 compared to finasteride in BPH patients

April 15, 1997

Furosemide vs. placebo for nocturnal polyuria

April 15, 1997

Initial clinical results with vinpocetine for urge incontinence

April 15, 1997

Mechanism of impaired erection with finasteride elucidated

April 15, 1997

Development of Auriculin suspended

April 14, 1997

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

Synthelabo reports agents for urinary incontinence

April 11, 1997

GelTex reports preliminary phase IIc results for RenaGel

April 10, 1997

Urologix's PMA for T3 System accepted for review

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...